Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency and Functionality: a Single Arm Study

Description

This research will explore the effect of the Transcendental Meditation® Technique on migraine intensity and frequency. It will be a single-arm pilot study involving 30 participants recruited from migraine treatment facilities and support groups in the US.

Conditions

Migraine, Migraine with or Without Aura

Talk to us

Study Overview

On this page

Study Details

Study overview

This research will explore the effect of the Transcendental Meditation® Technique on migraine intensity and frequency. It will be a single-arm pilot study involving 30 participants recruited from migraine treatment facilities and support groups in the US.

Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency and Functionality: a Single Arm Study

Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency and Functionality: a Single Arm Study

Condition
Migraine
Intervention / Treatment

-

Contacts and Locations

Washington

Georgetown Headache Center and DC area, Washington, District of Columbia, United States, 20036

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosis of migraine with or without aura, based on ICHD3 criteria
  • * 6-14 migraine days/month.
  • * ≥ one year history of migraines starting before the age of 50.
  • * ≥ 18 years old or ≤ 55 Years old
  • * Willing to attend follow-up sessions.
  • * Willing to practice TM twice a day for 20 minutes.
  • * Agreeable to participate and to be randomized to either group.
  • * Fluent in English.
  • * \> 55 years old or \< 18 Years old
  • * Already practicing Transcendental Meditation.
  • * Pre-diagnosed major systemic illness or unstable medical/psychiatric condition (eg, suicide risk) requiring immediate treatment or that could compromise protocol adherence
  • * Medication overuse headache (MOH)
  • * Current/planned pregnancy or breastfeeding
  • * New prophylactic migraine medicine started within 4 weeks of the screening visit
  • * Unwilling to maintain stable migraine medication dosages
  • * Failure to complete baseline headache logs.

Ages Eligible for Study

18 Years to 55 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Maharishi International University,

Dr. Fred T Travis, PhD, STUDY_CHAIR, Maharishi International University

Study Record Dates

2025-12